Smad3 deficient mice represent an interesting model to study parkinsonism due to the effects on nigrostriatal dopaminergic neurodegeneration and α-synuclein aggregation [22], where overexpression of α-synuclein may also play a role on hippocampal neurogenesis [74]. The gene discussed is SMAD3; the disease is Parkinson disease.